This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: AA BAC NFLX GOOG SO


Alcoa (AA - Get Report) was upgraded at RBC Capital to sector perform from underperform. Twelve-month price target is $15. Performance in the alumina business and GRP has been stronger than expected, RBC Capital said.

Anglogold Ashanti (AU) was downgraded to sell at TheStreet Ratings.

Bank of America (BAC - Get Report) was upgraded at Oppenheimer to outperform from perform. Twelve-month price target is $19. Future legal costs appear to be finite and manageable, Oppenheimer said.

Must Read: Analysts' Actions: AMZN TWC TWTR YELP YHOO

BofI Holding (BOFI) was upgraded at Sterne Agee to buy from neutral. Twelve-month price target is $92. H&R Block deal should be solidly accretive to earnings, Sterne Agee said.

Carnival (CCL) was downgraded to hold at TheStreet Ratings.

Edison International (EIX) was upgraded at Jefferies to buy from hold. Valuation call based on 12-month price target of $64.50, Jefferies said.

Enterprise Products Partners (EPD) was downgraded at Jefferies to hold from buy. Valuation call on 12-month price target of $75, Jefferies said.

Gogo (GOGO) was upgraded at J.P. Morgan to overweight from neutral. Twelve-month price target is $28. Stock has pulled back 17% this month, and the company can continue to grow both overseas and abroad, J.P. Morgan said.

Medicines Co. (MDCO) was downgraded at Leerink Swann to market perform from outperform. Twelve-month price target is $27. Company could face earlier generic competition for Angiomax, Leerink Swann said.

Meredith (MDP) was downgraded at Citigroup to neutral from buy. Twelve-month price target is $48. Company is seeing multiple signs of a potential market slowdown, Citigroup said.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AA $11.18 0.22%
BAC $14.56 -1.60%
AAPL $93.43 -1.50%
FB $116.31 -0.36%
GOOG $692.92 0.27%


Chart of I:DJI
DOW 17,701.60 -129.16 -0.72%
S&P 500 2,059.78 -16.03 -0.77%
NASDAQ 4,765.0410 -40.25 -0.84%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs